Article Text

PDF
Enhanced expression of mRNA for Krüppel-like factor 5 in CD34+ cells of the bone marrow in rheumatoid arthritis
  1. S Hirohata1,
  2. Y Miura2,
  3. T Tomita3,
  4. H Yoshikawa3
  1. 1
    Department of Rheumatology and Infectious Diseases, Kitasato University School of Medicine, Kanagawa, Japan
  2. 2
    Faculty of Health Sciences, Kobe University School of Medicine, Kobe, Japan
  3. 3
    Department of Orthopedic Surgery, Osaka University Medical School, Osaka, Japan
  1. Dr S Hirohata, Department of Rheumatology and Infectious Diseases, Kitasato University School of Medicine, 1-15-1 Kitasato, Sagamihara, Kanagawa 228–8555 Japan; shunsei_tenpoint{at}yahoo.co.jp

Statistics from Altmetric.com

Bone marrow (BM) CD34+ cells in rheumatoid arthritis (RA) have abnormal capacities to respond to tumour necrosis factor alpha (TNFα) and to differentiate into fibroblast-like cells producing matrix metalloproteinase type 1, suggesting that BM CD34+ progenitor cells might generate type B synoviocytes.1 Of note, RA BM CD34+ cells show enhanced expression of nuclear factor kappa B1 (NFκB1) (p50), the silencing of which resulted in the prevention of fibroblast-like cell differentiation.2 Krüppel-like factor 5 (KLF-5), a zinc finger-containing transcription factor, activates many genes, including platelet-derived growth factor (PDGF) A/B, plasminogen activator inhibitor-1, inducible nitric oxide synthase and vascular endothelial growth factor receptors.3 4 KLF-5 has been shown to cooperate with NFκB1 to activate PDGF-A gene expression,4 5 which might be involved in synovial fibroblast-like cell proliferation.6 We explored KLF-5 messenger RNA expression in RA BM CD34+ cells to delineate the mechanism …

View Full Text

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.